4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001013762-23-001295
Chief Scientific Officer acquired 2,569,458 shares (conversion)
- Chief Scientific Officer returned 2,569,458 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Reich Kristian · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-01 | Conversion : show line 1 in the form | +2,527,477 | 3,027,483 | I |
| 2023-10-01 | Returned to the company : show line 2 in the form | −2,527,477 | 0 | I |
| 2023-10-01 | Conversion : show line 3 in the form | +41,981 | 140,071 | D |
| 2023-10-01 | Returned to the company : show line 4 in the form | −41,981 | 196,316 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-01 | Conversion : show line 5 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG | −75,136 | 0 | I |
| 2023-10-01 | Conversion : show line 6 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,248 | 5,836 | D |
Loading xslF345X05/ownership.xml…